Press Release – INDIVA Congratulates Bhang Corporation on CSE Listing

Not for distribution to U.S. Newswire Services or for dissemination in the United States.

INDIVA

INDIVA Congratulates Bhang Corporation on CSE Listing

LONDON, Ontario – July 16, 2019:  Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (US:NDVAF) congratulates Bhang Corporation (“Bhang“) on its recent Canadian Securities Exchange listing (CSE: BHNG). Bhang is a trusted cannabis house of brands with a portfolio of more than 100 cannabis, hemp-derived cannabidiol (CBD) and terpene products. With more than 30 awards, including eight top placements at High Times’ Cannabis Cup and a High Times’ World Cup for “Best Edible,” Bhang is seen as an international leader in creative and high-quality cannabis products.

In 2018, Indiva and Bhang announced the establishment of a 50/50 joint venture to distribute a full range of cannabis products, including chocolates, gums and oral sprays, isolates, vapes and vape cartridges, and accessories. Through the joint venture, Indiva and Bhang expect to manufacture and distribute Bhang’s award-winning products in Canada as well as export such products internationally.

“Bhang consistently sets itself apart from the field with its creativity and quality. Bhang’s CSE listing announcement represents years of diligent work by Bhang’s leadership and a deep understanding of the evolving global appetite for cannabis and cannabis-infused products,” Niel Marotta, Indiva’s President and Chief Executive Officer said. “As Bhang’s exclusive Canadian partner, we celebrate their continued growth and look forward to bringing their innovative edibles to Canadians in the near future.”

Bhang’s milk chocolate recently received first place honours at WeedCon West in the “Best Cannabis Infused Chocolate” category. Subject to applicable regulatory approvals, Indiva, through the joint venture with Bhang, expects to offer that same award-winning chocolate, along with dark chocolate and additional varieties and flavours, to Canadian consumers in late 2019 or early 2020, when such products are expected to be permitted for sale in Canada.

 

About Indiva

Indiva’s global family of cannabis brands sets the standard for quality and innovation. Indiva aims to bring its exceptional portfolio of products to Canadians and cannabis enthusiasts around the world as laws permit. Indiva’s production facility, based in London, Ontario, includes aeroponic, environmentally-conscious grow rooms, as well as a 70-tonne extraction operation that we expect to include manufacturing and processing capabilities to make safe, high-quality cannabis-infused edibles. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, the award-winning Bhang Chocolate, and other derivative products through license agreements and joint ventures, subject to applicable regulatory approvals. Click here to connect with INDIVA on social media and here to find more information on the Company and its products.

 

About Bhang

Bhang is committed to delivering exceptional sensory experiences to consumers at every point in their cannabis journey through its award-winning portfolio of brands. Bhang is a trusted cannabis house of brands with an extensive portfolio of over 100 cannabis, hemp-derived CBD and terpene products, including chocolates, pre-rolls, vapes, gums, beverages, gummies and mouth sprays, among others, that are sold by its licensees and/or by Bhang directly. Since 2010, Bhang has mastered the art of harnessing mutually-beneficial partnerships to bring safe, consistent and delicious products to consumers. Learn more at bhangnation.com.

 

MEDIA CONTACT
Kate Abernathy
Vice President of Communications
Phone: 613-296-5764
Email: [email protected]

 

INVESTOR CONTACT
Steve Low
Investor Relations
Phone: 647-620-5101
Email: [email protected]

 

DISCLAIMER & READER ADVISORY

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future product offerings and entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

 

subscribe to news